STAT October 15, 2024
Sally Littlefield

The psychiatric health care system must earn back my trust before I try Cobenfy

On Sept. 26, the FDA approved the first truly new antipsychotic in decades: Cobenfy. In clinical trials, it didn’t cause certain side effects that traditionally interfere with medication adherence, including weight gain, lethargy, and movement disorders.

I have schizoaffective disorder, bipolar type...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Provider
Healthcare leaders to ramp up budgets for patient experience: 4 notes
The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights
1st health system attains stillbirth center of excellence designation
Effective and Lasting Hospital-at-Home Solutions Require Intentional Innovation and Design
How hospitals pick digital health vendors

Share This Article